
Management of cryptococcal meningitis in HIV-infected patients: Experience from western India
Author(s) -
Atul Patel,
Ketan Patel,
Ravi Ranjan,
Shalin Shah,
Jagdish K. Patel
Publication year - 2010
Publication title -
indian journal of sexually transmitted diseases
Language(s) - English
Resource type - Journals
eISSN - 1998-3816
pISSN - 0253-7184
DOI - 10.4103/0253-7184.68996
Subject(s) - medicine , cryptococcal meningitis , human immunodeficiency virus (hiv) , meningitis , pediatrics , family medicine , virology , viral disease
Cryptococcal meningitis is one of the acquired immunodeficiency syndrome defining infections with high mortality. Amphotericin B is the preferred drug for induction therapy. Despite advances in human immunodeficiency virus (HIV) treatment, Antiretroviral Treatment (ART) roll-out programs and availability of amphotericin B, cryptococcal meningitis remains an important cause of mortality in the African and other developing countries.